High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score

por Bodelier, Alexander G. L., Jonkers, Daisy, van den Heuvel, Tim, de Boer, Evelien, Hameeteman, Wim, Masclee, Ad A. M., Pierik, Marie J.
Publicado 2016

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease

por Galazzo, Gianluca, Tedjo, Danyta I, Wintjens, Dion S J, Savelkoul, Paul H M, Masclee, Ad A M, Bodelier, Alexander G L, Pierik, Marie J, Jonkers, Daisy M A E, Penders, John
Publicado 2019

Impact of timing of primary ileocecal resection on prognosis in patients with Crohn’s disease

por Beelen, Evelien M J, Arkenbosch, Jeanine H C, Erler, Nicole S, Sleutjes, Jasmijn A M, Hoentjen, Frank, Bodelier, Alexander G L, Dijkstra, Gerard, Romberg-Camps, Marielle, de Boer, Nanne K, Stassen, Laurents P S, van der Meulen, Andrea E, West, Rachel, van Ruler, Oddeke, van der Woude, C Janneke, de Vries, Annemarie C
Publicado 2023

Comorbidity, not patient age, is associated with impaired safety outcomes in vedolizumab‐ and ustekinumab‐treated patients with inflammatory bowel disease—a prospective multicentre...

por Asscher, Vera E. R., Biemans, Vince B. C., Pierik, Marieke J., Dijkstra, Gerard, Löwenberg, Mark, van der Marel, Sander, de Boer, Nanne K. H., Bodelier, Alexander G. L., Jansen, Jeroen M., West, Rachel L., Haans, Jeoffrey J. L., van Dop, Willemijn A., Weersma, Rinse K., Hoentjen, Frank, Maljaars, P. W. Jeroen
Publicado 2020

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

por Biemans, Vince B C, van der Meulen - de Jong, Andrea E, van der Woude, Christine J, Löwenberg, Mark, Dijkstra, Gerard, Oldenburg, Bas, de Boer, Nanne K H, van der Marel, Sander, Bodelier, Alexander G L, Jansen, Jeroen M, Haans, Jeoffrey J L, Theeuwen, Rosaline, de Jong, Dirk, Pierik, Marie J, Hoentjen, Frank
Publicado 2020

Vedolizumab for Inflammatory Bowel Disease: Two‐Year Results of the Initiative on Crohn and Colitis (ICC) Registry, A Nationwide Prospective Observational Cohort Study: ICC Registr...

por Biemans, Vince B.C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Oldenburg, Bas, de Boer, Nanne K., Löwenberg, Mark, Srivastava, Nidhi, Bodelier, Alexander G.L., West, Rachel L., Jansen, Jeroen M., de Vries, Annemarie C., Haans, Jeoffrey J.L., de Jong, Dirk J., Pierik, Marie J., Hoentjen, Frank
Publicado 2019

Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn’s disease patients with prior failure to anti‐TNF treatment

por Biemans, Vince B. C., van der Woude, C. Janneke, Dijkstra, Gerard, van der Meulen‐de Jong, Andrea E., Löwenberg, Mark, de Boer, Nanne K., Oldenburg, Bas, Srivastava, Nidhi, Jansen, Jeroen M., Bodelier, Alexander G. L., West, Rachel L., de Vries, Annemarie C., Haans, Jeoffrey J. L., de Jong, Dirk, Hoentjen, Frank, Pierik, Marieke J.
Publicado 2020

Effectiveness and safety of tofacitinib for ulcerative colitis: two‐year results of the ICC Registry

por Straatmijer, Tessa, van Schaik, Fiona D. M., Bodelier, Alexander G. L., Visschedijk, Marijn, de Vries, Annemarie C., Ponsioen, Cyriel Y., Pierik, Marieke, van Bodegraven, Ad A., West, Rachel L., de Boer, Nanne K. H., Srivastava, Nidhi, Romkens, Tessa E. H., Hoekstra, Jildou, Oldenburg, Bas, Dijkstra, Gerard, van der Woude, Janneke C., Löwenberg, Mark, Mujagic, Zlatan, Biemans, Vince B. C., van der Meulen‐de Jong, Andrea E., Duijvestein, Marjolijn
Publicado 2022

Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

por Biemans, Vince B. C., Sleutjes, Jasmijn A. M., de Vries, Annemarie C., Bodelier, Alexander G. L., Dijkstra, Gerard, Oldenburg, Bas, Löwenberg, Mark, van Bodegraven, Adriaan A., van der Meulen‐de Jong, Andrea E., de Boer, Nanne K. H., Srivastava, Nidhi, West, Rachel L., Römkens, Tessa E. H., Horjus Talabur Horje, Carmen S., Jansen, Jeroen M., van der Woude, C. Janneke, Hoekstra, Jildou, Weersma, Rinse K., van Schaik, Fiona D. M., Hoentjen, Frank, Pierik, Marieke J.
Publicado 2020

Clinical Outcomes of Covid-19 in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study

por Derikx, Lauranne A A P, Lantinga, Marten A, de Jong, Dirk J, van Dop, Willemijn A, Creemers, Rob H, Römkens, Tessa E H, Jansen, Jeroen M, Mahmmod, Nofel, West, Rachel L, Tan, Adriaan C I T L, Bodelier, Alexander G L, Gorter, Moniek H P, Boekema, Paul J, Halet, Eric R C, Horjus, Carmen S, van Dijk, Maarten A, Hirdes, Meike M C, Epping Stippel, Ludger S M, Jharap, Bindia, Lutgens, Maurice W M D, Russel, Maurice G, Gilissen, Lennard P L, Nauta, Sjoukje, van Bodegraven, Adriaan A, Hoentjen, Frank
Publicado 2020

Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn’s Disease Patients in Stable Remission: The Randomized Controlled LADI Trial

por Jansen, Fenna M, van Linschoten, Reinier C A, Kievit, Wietske, Smits, Lisa J T, Pauwels, Renske W M, de Jong, Dirk J, de Vries, Annemarie C, Boekema, Paul J, West, Rachel L, Bodelier, Alexander G L, Gisbertz, Ingrid A M, Wolfhagen, Frank H J, Römkens, Tessa E H, Lutgens, Maurice W M D, van Bodegraven, Adriaan A, Oldenburg, Bas, Pierik, Marieke J, Russel, Maurice G V M, de Boer, Nanne K, Mallant-Hent, Rosalie C, ter Borg, Pieter C J, van der Meulen-de Jong, Andrea E, Jansen, Jeroen M, Jansen, Sita V, Tan, Adrianus C I T L, Hoentjen, Frank, van der Woude, C Janneke
Publicado 2023